Globus Medical Acquires Stake in Synoste from Evonik

illustration of Synoste's limb lengthening implant

Evonik Venture Capital sold its stake in Synoste Oy to Globus Medical. Evonik did not disclose the deal's financial terms. Synoste is a Finnish start-up that developed a minimally invasive implant for the treatment of leg length discrepancy, pictured above. The implant lengthens the bone gradually over a period of months and is manufactured...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us